A new approach to predict evolution of influenza viruses can enhance vaccine efficacy

December 7, 2015, University of Helsinki

New results from a study performed at the University of Helsinki suggest that genomic information from circulating influenza viruses can help in producing more efficient seasonal vaccines. The researchers were able to develop a simple approach for reliable real-time tracking and prediction of viral evolution based on whole-genome sequences of influenza viruses.

Influenza vaccines have been developed to prevent the yearly outbreaks of this respiratory illness and to protect people at risk from developing severe disease. In contrast to many other vaccines, need to be reformulated each year because circulating influenza viruses continuously evolve. This evolution is due to the ability of viruses to accumulate new mutations in their genome. Especially critical are those genomic regions that encode viral proteins recognized by the human immune system.

World Health Organization (WHO) is responsible for predicting the influenza that will be most common during the next season and for giving recommendations on the particular virus strains that should be used for producing the vaccines for the next . The effectiveness of the vaccines varies from year to year and was modest for the previous season. This could be due to antigenic mismatch between the circulating and the recommended by the WHO.

Researchers from the Institute for Molecular Medicine Finland, FIMM, the University of Helsinki, have now analysed thousands of complete genome sequences of influenza A(H1N1) and A(H3N2) strains representing different geographic regions. The study was done in collaboration with researchers from Singapore and United Kingdom. By utilizing biostatistical methods, the team was able to identify several genetic variants that changed the structure of the influenza proteins and that were present in surprisingly many of the strains studied.

"We named these characteristic variants as evolutionary markers as they seemed to contain valuable information regarding the viral evolution," explains Denis Kainov, the leader of the research team.

Furthermore, the group was able to show that both influenza subtypes acquired their own sets of these evolutionary markers. Importantly, many of these markers were not present in the virus strains used for the vaccine development during the last season.

"We believe that our results and methodology could further improve vaccine strain selection process and, thereby, enhance vaccine efficacy. Each year a substantial number of Finns gets influenza. We estimated that if the vaccination efficacy increases by 50%, this would save up to 8 000 people from getting the disease in Finland alone. Our team proposes using the strains containing all the identified evolutionary markers as vaccine candidates for upcoming seasons," Kainov continues.

Explore further: Scientists pinpoint mutations responsible for ineffective 2014-2015 flu vaccine

More information: Sergei S. Belanov et al. Genome-wide analysis of evolutionary markers of human influenza A(H1N1)pdm09 and A(H3N2) viruses may guide selection of vaccine strain candidates, Genome Biology and Evolution (2015). DOI: 10.1093/gbe/evv240

Related Stories

Scientists pinpoint mutations responsible for ineffective 2014-2015 flu vaccine

June 25, 2015
Viruses like influenza have the ability to mutate over time, and given that the flu vaccines administered during the 2014-2015 season were largely ineffective at preventing the spread of the flu, it appears the virus that ...

Enhanced flu protection: Adding a second strain of B flu lessens likelihood of mismatched vaccine

March 13, 2015
A flu vaccine given just under the surface of the skin that includes four strains of inactivated influenza could be more protective than a similar flu vaccine containing only three strains, Saint Louis University research ...

CDC tweaking flu vaccine for better protection

June 5, 2015
(HealthDay)—Having acknowledged that the 2014-2015 flu vaccine was mismatched to the circulating influenza strains, U.S. health officials have ramped up next season's shots for broader protection.

Influenza vaccines provide moderate protection throughout the entire flu season

August 24, 2015
Individuals who received the flu vaccine were protected for up to 6 months post-vaccination, the duration of most flu seasons, according to a study presented at the 2015 International Conference on Emerging Infectious Diseases.

Flu study, on hold, yields new vaccine technology

September 2, 2015
Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today by researchers at the University of Wisconsin-Madison in the ...

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

Recommended for you

Cancer drug helps treat tuberculosis by restoring leaky blood vessels

April 26, 2018
Biomedical engineers have discovered an unlikely potential ally in the global fight against tuberculosis—an FDA-approved drug originally designed to treat cancer.

Molecule may help tame virulent bacteria and prevent infection

April 26, 2018
According to the U.S. Centers for Disease Control and Prevention, about one in three humans carries Staphylococcus aureus, or "staph," in our noses, and 2 percent of us carry the dreaded methicillin-resistant (MRSA) strain ...

Antibody 'cocktail' can prevent Zika infection but is not effective for treatment of fetuses

April 26, 2018
A "cocktail" of monoclonal antibodies that can prevent Zika virus (ZIKV) infection in primates was not effective for treatment of fetuses, according to a new collaborative study led by a University of Miami Miller School ...

E. coli—are we measuring the wrong thing?

April 25, 2018
A sepsis awareness and management programme has demonstrated overall success in terms of improved sepsis detection, but has led to an increase in the number of E. coli blood stream infection cases presented, calling into ...

Malaria study reveals gene variants linked to risk of disease

April 25, 2018
Many people of African heritage are protected against malaria by inheriting a particular version of a gene, a large-scale study has shown.

Commonly prescribed heartburn drug linked to pneumonia in older adults

April 24, 2018
Researchers at the University of Exeter have found a statistical link between pneumonia in older people and a group of medicines commonly used to neutralise stomach acid in people with heartburn or stomach ulcers. Although ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.